Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-25-240437

General Counsel and Secretary sold 1,076 shares at $66.60 ($71,662)

  • General Counsel and Secretary acquired 2,114 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KASINGER JAMES R. · General Counsel and Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-13 Exercise or conversion : show line 1 in the form +2,114 84,478 D
2025-10-14 Sale : show line 2 in the form −1,076 $66.60 $71,662 83,402 D
Open-market sales · 1,076 sh · avg $66.60 · $71,662

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-13 Exercise or conversion : show line 3 in the form Restricted Stock Units −2,114 2,113 D
Loading xslF345X05/ownership.xml…